News

logo LSFM4LIFE horizontal transparent cropped

Cellendes receives EU funding for development of hydrogels for Type 1 Diabetes cell therapy.

Cellendes becomes network partner of the Competence Centre Tissue Engineering for Drug Development (TEDD) at the ZHAW, W├Ądenswil, Switzerland.

Cellendes expands its biomimetic hydrogel product line.